Edition:
United Kingdom

IRLAB Therapeutics AB (IRLABa.ST)

IRLABa.ST on Stockholm Stock Exchange

90.00SEK
25 Jun 2019
Change (% chg)

-0.30kr (-0.33%)
Prev Close
90.30kr
Open
90.30kr
Day's High
90.30kr
Day's Low
88.20kr
Volume
10,426
Avg. Vol
16,094
52-wk High
98.00kr
52-wk Low
39.00kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.438
FY 2018 Dec '18 0.02 -0.459
Sep '18 0.00 -0.390
Jun '18 0.00 -0.646
Mar '18 0.00 -0.453
FY 2017 Dec '17 0.01 -0.371
Sep '17 0.05 -0.591
Jun '17 0.00 -0.304
Mar '17 0.04 -0.397
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 1 82.00 82.00 82.00 82.00
Year Ending Dec-20 1 325.00 325.00 325.00 283.00
Earnings (per share)
Year Ending Dec-19 1 -0.59 -0.59 -0.59 -0.40
Year Ending Dec-20 1 5.39 5.39 5.39 4.88
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.55
P/E High - Last 5 Yrs. -- 43.17 48.11
P/E Low - Last 5 Yrs. -- 22.71 23.41
Beta -- 0.86 0.87
Price to Sales (TTM) 7,168.96 6.60 8.44
Price to Book (MRQ) 5.53 5.12 5.27
Price to Tangible Book (MRQ) 9.89 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.71
Payout Ratio(TTM) -- 42.19 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -89.58 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.04
Sales - 5 Yr. Growth Rate -- 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.96 46.17 48.19
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 21.56 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.87 11.35
Total Debt to Equity (MRQ) 0.00 12.87 16.04
Interest Coverage (TTM) -- 32.47 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -23,572.92 52.06 52.36
Gross Margin - 5 Yr. Avg. -- 49.67 50.39
EBITD Margin (TTM) -31,530.55 -- --
EBITD - 5 Yr. Avg -- 17.26 12.41
Operating Margin (TTM) -31,768.75 13.47 5.62
Operating Margin - 5 Yr. Avg. -- 13.69 8.00
Pre-Tax Margin (TTM) -33,165.28 11.82 4.64
Pre-Tax Margin - 5 Yr. Avg. -- 14.09 8.28
Net Profit Margin (TTM) -33,165.28 8.73 1.37
Net Profit Margin - 5 Yr. Avg. -- 10.58 4.69
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 16,000 928,391,941 819,624,671
Net Income/Employee (TTM) -5,306,445 105,138,175 92,776,869
Receivable Turnover (TTM) 0.07 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.42
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.25 10.98 10.65
Return on Assets - 5 Yr. Avg. -- 12.41 11.77
Return on Investment (TTM) -30.09 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -30.13 15.46 15.24
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -45.05 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for IRLAB Therapeutics AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.30 -- 81 30
13 Week 5.67 -- 99 42
26 Week 214.35 -- 99 43
52 Week -- -- -- 11
YTD -- -- -- 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.22%
# of Holders: 2
Total Shares Held: 1,695,855
3 Mo. Net Change: -42,485
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.